View Author
stent patient group lesion study sirolimus-eluting restenosi percent target sirolimus-eluting stents artery target lesion luminal diameter revascularization vessel procedure diameter month circulation trial luminal sirolimu treatment stenosi sirolimus-eluting stent follow-up copyright 2002 massachusetts angina 3 years sirolimus-stent group implantation in-stent randomized angiographic event result in-stent restenosis control group standard-stent group sirolimus-eluting stent group infarction percutaneou france ravel neointimal difference www.nejm.org intravascular sousa right ultrasound target vessel point comparison serruy 50 percent luminal loss sirolimus-stent control survival drug-eluting device popma jj index standard-stent stenting <0.001 percentage table society p <0.001 randomized comparison angioplasty netherland bare-metal stents serruys pw massachusett rotterdam copyright neointimal proliferation
2 Most Recent Publications
|
Maintenance of long-term clinical benefit with sirolimus-eluting coronary stents: three-year results of the RAVEL trial.
(Article)
Fajadet, J. Morice, M-C. Laarman, G-J. Perin, M.A. Sousa, J.E. Schuler, G. Molnar, F. Guagliumi, G. Colombo, A. Ban Hayashi, E. Wülfert, E. Barragan, P. Serruys, P.W.J.C. Wijns, W. Constantini, C. Guermonprez, J-L. Eltchaninoff, H. Blanchard, D. Bartorelli, A. |
2005-03-01
|
|
A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
(Article)
Morice, M-C. Guagliumi, G. Barragan, P. Serruys, P.W.J.C. Falotico, R. Molnar, F. Sousa, J.E. Fajadet, J. Ban Hayashi, E. Perin, M.A. Colombo, A. Schuler, G. |
2002-01-01
|
